Industry
Middle East In Vitro Diagnostics Market Worth USD3.4 Billion by 2021
The Middle East market for in vitro diagnostics will be worth USD 3.4 billion by 2021 and record a growth that is one and one-half to double that of the world IVD market. The growth will be driven by expanding populations and a commitment to healthcare spending in this region, which houses offices of most global concerns in Saudi Arabia, Egypt, Dubai or other locales to service this population with testing products and supplies. More...14 Oct 2016
Danaher Corporation to Acquire Phenomenex
Danaher Corporation will acquire Phenomenex Inc., a privately held manufacturer and distributor of high-value consumables for the separation sciences, including proprietary chromatography consumables for the liquid and gas chromatography market. More...14 Oct 2016
Instrumentation Laboratory Acquires CA Casyso
Instrumentation Laboratory (IL), which manufactures instruments and reagents for the global hemostasis market, has acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a provider of in vitro diagnostic (IVD) testing for patient blood management (PBM). More...26 Sep 2016
Global In Vitro Diagnostic Test Market Worth USD 60 Billion
The global in vitro diagnostic (IVD) test market is currently worth USD 60.5 billion and will continue to grow, though a moderate and gradual change is likely to be witnessed over the next five to ten years, as more opportunities are created in novel tests and growing regions, while the traditional categories and reliable large markets face challenges. More...26 Aug 2016
Critical Care Diagnostics Market Worth USD 1.29 Billion By 2024
The global critical care diagnostics (CCD) market will grow at a lucrative rate over the next few years to reach USD 1.29 billion by 2024, driven by the rapid awareness and acknowledgment of these tests by physicians and patients, rise in geriatric population and chronic health conditions, use of telehealth services in remote areas, and technological advancements. However, increased cost of molecular diagnostics and shortage of skilled labor to handle new platforms are expected to hinder the industry’s growth. More...16 Aug 2016
LabCorp to Acquire Sequenom
Laboratory Corporation of America Holdings (LabCorp) (Burlington, NC, USA), a healthcare diagnostics company, and Sequenom, Inc. (San Diego, CA, USA), which is in the business of non-invasive prenatal testing (NIPT) for reproductive health, have entered into a definitive agreement and plan of merger. More...01 Aug 2016
In Other News
Global Digital Pathology Market Worth USD 1,052 Million by 2022
Blood Gas and Electrolyte Analyzer Market Worth USD 636 Million by 2021
Cardiac Biomarker Testing Market Reaches $2 Billion
PoC Diagnostics Market Worth $36.96 Billion by 2021
Agilent Technologies to Acquire Assets of iLab Solutions
Beckman Coulter and Ortho Clinical Partner to Deliver Infectious Disease Testing Menu
Luminex Enters Agreement to Acquire Nanosphere
Sysmex and Siemens Extend Partnership in Hemostasis Testing
In Vitro Diagnostics Market to Witness Swift Growth
DiaSorin Enters U.S. Molecular and Immunoassay Market
R-Biopharm and Merck Partner on Companion Diagnostics
Near-Patient Molecular Diagnostics Forecasted to USD 1 Billion
HTG Molecular Diagnostics Announces IVD Development Agreement with Thermo Fisher Scientific
Frozen Section Analysis for Breast Cancer Saves Time
Continued Growth Expected for Molecular POC Testing
Clinical Laboratory Services Introduce Diagnosis of Invasive Fungal Infections
Lab Information Systems Sector Reaches 1 Billion
Multifaceted Intervention Reduces In-Patient Laboratory Costs
Arquer and Euro Diagnostica Partner on Noninvasive Test for Bladder Cancer
Collaboration Helps Accelerate Launch of New Malaria Test
Abbott to Gain Leadership in POC Diagnostics upon Acquisition of Alere
IVD Sector in India Shows Stable Growth and Exhibits Potential
Thermo Fisher to Acquire Affymetrix, Strengthens Biosciences Leadership
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.